Sort by
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Therapeutic Target
100%
Alzheimer's Disease
100%
Alzheimer's Type
100%
Matrix metalloprotease-9
100%
Angiogenesis
28%
Disease Progression
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Insulin Resistance
14%
Pancreas
14%
Blood-brain Barrier
14%
Therapeutic Use
14%
Neurogenesis
14%
Wound Healing
14%
Tumor Metastasis
14%
Cell Surface Receptor
14%
Physiological Processes
14%
Apoptosis
14%
Signaling Molecules
14%
Neurodegenerative Diseases
14%
Putative Drug Targets
14%
Demyelination
14%
Combinatorial Strategies
14%
Physiological Events
14%
Common Denominator
14%
Beneficial Effects
14%
Type IV Collagen
14%
Apoptosis Inhibition
14%
Axonal Growth
14%
Extracellular Matrix Protein 1 (ECM1)
14%
Extracellular Matrix Degradation
14%
Pathological Process
14%
Amyloid Deposition
14%
Tissue Remodeling
14%
Endopeptidase
14%
Matrix Effect
14%
Amyloidogenesis
14%
Pathological Progression
14%
Amyloid Accumulation
14%
Destructive Behavior
14%
Pharmacology, Toxicology and Pharmaceutical Science
Metalloproteinase
100%
Alzheimer's Disease
100%
Maturity Onset Diabetes of the Young
100%
Diseases
85%
Amyloid Protein
28%
Therapeutic Use
14%
Disease Exacerbation
14%
Receptor
14%
Wound Healing
14%
Gelatinase A
14%
Demyelination
14%
Insulin Resistance
14%
Blood-Brain Barrier
14%
Biochemistry, Genetics and Molecular Biology
Metalloproteinase
100%
Metalloendopeptidase
100%
Angiogenesis
28%
Amyloid Protein
28%
Programmed Cell Death
28%
Nervous System Development
14%
Wound Healing
14%
Blood Brain Barrier
14%
Insulin Resistance
14%
Gelatinase A
14%
MMP2
14%
Protease
14%